SEOUL, SOUTH KOREA, February 5, 2024 /EINPresswire.com/ -- Deep Bio, a pioneer of AI-powered cancer diagnostics solutions, proudly announced the inclusion of DeepDx Prostate in CancerX's Solutions Catalog. This significant participation...

DeepBio won the CES Innovation Award for pioneering a new milestone in Korean cancer diagnosis A.I. solutions. SEOUL, South Korea, Nov. 20, 2023 /PRNewswire/ -- DeepBio announced today that it has been awarded the CES Innovation Award as...

DeepBio won the CES Innovation Award for pioneering a new milestone in Korean cancer diagnosis A.I. solutions. SEOUL, South Korea, Nov. 20, 2023 /PRNewswire/ -- DeepBio announced today that it has been awarded the CES Innovation Award as...

Invitation from Deep Bio: Our team is ready to greet you at booth #3445! Find out how DeepDx® Prostate empowers pathologists. Also, Deep Bio will present two research abstracts in relation to biomarker in prostate and breast cancers at...

Deep Bio: USCAP 2023 is sixth consecutive year of presenting research abstracts  SEOUL, SOUTH KOREA (PRWEB) MARCH 14, 2023 - Deep Bio, a pioneer in medical AI for digital pathology and cancer diagnostics support software shared three...

Dive Deeper into Data-Driven Pathology at USCAP 2023 with DeepBio. USCAP 2023, find us at booth #349 to learn more about our flagship product DeepDx® Prostate, among others, and what values they bring to pathology. Moreover, don't miss...